Name | Ipomoeassin F |
---|
Description | Ipomoeassin F is a potent and selective endoplasmic reticulum (ER) protein-translocation inhibitor by targeting the pore-forming subunit of the Sec61 complex (Sec61α) at the ER membrane. Ipomoeassin F selectively inhibits the ER membrane translocation of SARS-CoV-2 proteins. Ipomoeassin F block the ER translocation of secretory proteins and type I transmembrane proteins (TMPs), but not type III TMPs[1][2][3]. |
---|---|
Related Catalog | |
In Vitro | Ipomoeassin F (1-500 nM; 24 小时) 有效抑制 α1AT 易位到 ER[1]。 Ipomoeassin F 在人卵巢癌细胞系 A2780 中具有很强的活性,IC50 值为 0.036 μM[2]。 Western Blot Analysis[1] Cell Line: HepG2 cells Concentration: 1, 5, 10, 25, 50, 75, 100, 250, 500 nM Incubation Time: 24 h Result: Downregulated cellular ATP levels and inhibited Sec61-mediated protein translocation with comparable potency. |
References |
Molecular Formula | C44H62O15 |
---|---|
Molecular Weight | 830.95 |